Cardiovascular Seminar – Phil Ainslie
Friday, February 8, 2019
12:00 – 1:00 pm
Location: The Audion in STAR Tower
Phil Ainslie, PhD
University of British Columbia
Title: Extremes of Oxygen and the Human Brain: Evolution, Acclimatization, and Adaptation
Professor Phil Ainslie is an integrative human physiologist whose research aims to understand the mechanisms regulating brain blood flow in health and disease. His diverse expertise has involved the assessment of cerebrovascular function during physiological scenarios ranging from sleep to exercise, the stresses of high altitude to deep-sea diving, and healthy aging to heart disease. His work in cerebrovascular pathology encompasses the lifespan: from elucidating why children native to high altitude and obese children at sea-level exhibit cerebrovascular dysfunction, to more recent interventional research examining the combination of exercise and/or diet for the treatment of dementia related diseases.
Dr Ainslie’s industrious research program utilizes a vast network of international collaborators, and facilitates the ongoing training of numerous highly qualified personal, some of whom have been awarded the highest Canadian honors for their contributions to research in Canada. In July 2011, Dr Ainslie was awarded a prestigious 10-year Canada Research Chair in Cerebrovascular Physiology
Innovative Technology Seminar – Adam Persky
March 22, 2019
Title: Going from best practices to innovation in teaching and learning
Abstract: Innovation stems from best practices. In this session we will translate what we know from cognitive psychology, education, and physiology into practical application. There is a great deal of research pertaining to what works and what does not work with respect to student learning. At the conclusion of this session you will have a better understanding of what makes a best practice and how to improve and innovate for your classroom.
Motor Control Seminar – David Vaillancourt
April 12, 2019
David Vaillancourt, PhD
Department of Applied Physiology and Kinesiology, Biomedical Engineering, and Neurology
University of Florida
Vaillancourt’s research focuses on how the brain regulates movement with a specific focus on voluntary and involuntary motor disorders. His research program uses advanced neuroimaging techniques to study the functional and structural changes in the brain of people with movement disorders that span Parkinson’s disease, tremor, dystonia, and ataxia. He has conducted studies investigating interventions including rehabilitative, surgical, and pharmacological interventions, and published this work in journals that include Brain, Journal of Neuroscience, Science Translational Medicine, JAMA Neurology, Neurology, Human Brain Mapping, Neuroimage, Cerebral Cortex, and Neurobiology of Aging. He has been continuously funded by NIH since 1999, and now directs several grants from NIH. Active work in his lab includes progression studies focused on changes in the brain for Parkinson’s disease and Parkinsonism, studies of tremor and brain connectivity, and pharmacological and neuroimaging studies for dystonia in mouse and human. He has served as Chair of the NIH Study Section Motor Function Speech and Rehabilitation and reviews grants for the Michael J. Fox Foundation and National Parkinson Foundation. He has been primary mentor on both F32 and K-series awards from NIH. At UF, he created the course entitled “Movement Disorders” which is now the foundation course for a new T32 training grant from the NIH for training doctoral students in movement disorders.
Molecular Physiology Seminar – Denis Guttridge
September 17, 2018 @ 1:00 pm – 2:00 pm
Location: STAR Atrium
Denis Guttridge, PhD
Medical University of South Carolina
Director of the Darby Children’s Research Institute
Associate Director of Translational Science in the Hollings Cancer Center
Title: Insights Into Cancer Cachexia and What Patient Data Can Tell Us
Abstract: Cachexia is a multifactorial condition tightly associated with chronic illnesses including, but not limited to cancer, chronic obstructive pulmonary disease, heart failure, chronic kidney disease, and rheumatoid arthritis. The syndrome is characterized by depletion of skeletal muscle and adipose tissues leading to pronounced weight loss that severely impacts patient morbidity and mortality. For cancer, estimates indicate that the prevalence of cachexia is 50-80%, which accounts for 20% deaths. However, in advanced cancers such as pancreatic cancer, which has a high incidence of cachexia, the mortality rate climbs to a staggering 80%. Muscle wasting in cachexia is thought to be driven by principally two mechanisms, one regulated by the ubiquitin proteasome pathway and the other by the autophagy system. Both are activated in skeletal myofibers by inflammatory cytokines that act through specific transcription factors to mediate the expression of specific components of the proteasome and autophagy systems. However, another mechanism controlling muscle turnover, proposed more recently by our laboratory, involves the failure of skeletal muscle cells to properly regenerate during a cachexia condition. This latter mechanism will be discussed in more details in the lecture. A second point in the lecture will be to discuss the currently used mouse models of cancer cachexia and whether they accurately recapitulate the features of cachexia in pancreatic cancer patients.
Seminar hosted by Dr. Matthew Hudson in association with KAAP
Biomechanics Seminar – Elena Grabowski
October 26, 2018 @ 10:00 am – 11:00 am
Location: STAR Atrium
Alena Grabowski, PhD
VA Research Healthcare Scientist
Assistant Professor at the University of Colorado Boulder
Title: The effects of using running prostheses for athletes with transtibial amputations and implications for inclusion in Olympic track & field competition
Abstract: Running-specific leg prostheses (RSPs) are made of carbon fiber, mimic the spring-like function of tendons, and allow elastic energy storage and return during level-ground steady-speed running; however, unlike biological legs, passive-elastic RSPs cannot generate mechanical power anew, vary stiffness, or allow ground clearance during leg swing. Previous research shows that athletes with transtibial amputations (TTAs) using RSPs have different biomechanics across running speeds (Grabowski et al. 2010), impaired starting block acceleration (Taboga et al. 2014) and slower curve-running performance (Taboga et al. 2016) compared to non-amputees. Dr. Grabowski will present a series of studies that assess the biomechanics, metabolic costs, and performance of athletes with unilateral and bilateral TTAs who use RSPs for running, sprinting, and jumping. Specifically, she will present scientific research regarding the effects of using RSPs and the implications of these findings for fairness in sport competition such as the Olympic Games.
Seminar hosted by Dr. Elisa Arch in association with KAAP
Concussion Seminar – Anthony Kontos
November 30, 2018 @ 12:00 pm – 1:00 pm
Location: STAR Atrium
Anthony Kontos, PhD
Director of Research for the UPMC Sports Medicine Concussion Program
Associate Professor in the Department of Orthopaedic Surgery
University of Pittsburgh
Title: One Size Does NOT Fit All: A Clinical Profiles Approach to Concussion Assessment and Treatment
Abstract: Concussion is a heterogenous injury for which a “one size fits all” approach is ineffective. The current presentation will discuss an emerging clinical profiles approach to assessing and treating this injury. Emphasis will be on the role of a comprehensive assessment including risk factors, symptoms, cognitive, vestibular, ocular, and psychological tools. Targeted and active treatments will also be discussed. The overarching theme of the presentation is that concussion is a treatable injury.
Seminar hosted by Dr. Thomas Kaminski in association with KAAP